These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28856784)

  • 21. Update on current approaches to diagnosis and treatment of onychomycosis.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V
    Expert Rev Anti Infect Ther; 2018 Dec; 16(12):929-938. PubMed ID: 30411650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onychomycosis: Treatment and prevention of recurrence.
    Lipner SR; Scher RK
    J Am Acad Dermatol; 2019 Apr; 80(4):853-867. PubMed ID: 29959962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.
    Stewart CR; Algu L; Kamran R; Leveille CF; Abid K; Rae C; Lipner SR
    J Am Acad Dermatol; 2021 Nov; 85(5):1227-1239. PubMed ID: 32502586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and management strategies of onychomycosis.
    Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
    J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption.
    Becker P; Lecerf P; Claereboudt J; Devleesschauwer B; Packeu A; Hendrickx M
    Mycoses; 2020 May; 63(5):500-508. PubMed ID: 32048335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of terbinafine hydrochloride spray and 3% boric acid alcohol ear drops in otomycosis.
    Xu S; Li J; Ding L; Gao K; Xie F; Han J; Zhou X
    Acta Otolaryngol; 2020 Apr; 140(4):302-306. PubMed ID: 32022618
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in therapies for onychomycosis and its management.
    Gupta AK; Stec N
    F1000Res; 2019; 8():. PubMed ID: 31297182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study.
    Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S
    Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
    Ghannoum M; Long L; Kunze G; Sarkany M; Osman-Ponchet H
    Mycoses; 2019 Jun; 62(6):494-501. PubMed ID: 30667544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and Opportunities in the Management of Onychomycosis.
    Christenson JK; Peterson GM; Naunton M; Bushell M; Kosari S; Baby KE; Thomas J
    J Fungi (Basel); 2018 Jul; 4(3):. PubMed ID: 30042327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.
    Yousefian F; Smythe C; Han H; Elewski BE; Nestor M
    J Clin Aesthet Dermatol; 2024 Mar; 17(3):24-33. PubMed ID: 38495549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nail Society of India (NSI) Recommendations for Pharmacologic Therapy of Onychomycosis.
    Mahajan K; Grover C; Relhan V; Tahiliani S; Singal A; Shenoy MM; Jakhar D
    Indian Dermatol Online J; 2023; 14(3):330-341. PubMed ID: 37266092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated Perspectives on the Diagnosis and Management of Onychomycosis.
    Falotico JM; Lipner SR
    Clin Cosmet Investig Dermatol; 2022; 15():1933-1957. PubMed ID: 36133401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Paradigm Shift in the Treatment and Management of Onychomycosis.
    Gupta AK; Venkataraman M; Renaud HJ; Summerbell R; Shear NH; Piguet V
    Skin Appendage Disord; 2021 Aug; 7(5):351-358. PubMed ID: 34604322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
    Nakamura A; Hirakawa S; Nagai H; Inagaki K
    Med Mycol; 2021 Mar; 59(3):289-295. PubMed ID: 33539539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onychomycosis: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
    Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Foley KA
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28856784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.